Pesquisas alternativas:
during noisy » during noise (Expandir a Pesquisa), using noisy (Expandir a Pesquisa), during non (Expandir a Pesquisa)
doses liver » does liver (Expandir a Pesquisa), dose liver (Expandir a Pesquisa), dose live (Expandir a Pesquisa)
liver thle2 » liver three (Expandir a Pesquisa)
noisy model » noise model (Expandir a Pesquisa), noise models (Expandir a Pesquisa), daisy model (Expandir a Pesquisa)
level ther » level theory (Expandir a Pesquisa), level rather (Expandir a Pesquisa), levels other (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa), drug disease (Expandir a Pesquisa)
drug does » drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa), drug de (Expandir a Pesquisa)
during noisy » during noise (Expandir a Pesquisa), using noisy (Expandir a Pesquisa), during non (Expandir a Pesquisa)
doses liver » does liver (Expandir a Pesquisa), dose liver (Expandir a Pesquisa), dose live (Expandir a Pesquisa)
liver thle2 » liver three (Expandir a Pesquisa)
noisy model » noise model (Expandir a Pesquisa), noise models (Expandir a Pesquisa), daisy model (Expandir a Pesquisa)
level ther » level theory (Expandir a Pesquisa), level rather (Expandir a Pesquisa), levels other (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa), drug disease (Expandir a Pesquisa)
drug does » drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa), drug de (Expandir a Pesquisa)
1
“.... Next, the theory is used to model two-photon microscopy data that show, in animals, high rates...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
“... plethora of computational models, from equational to neural network form, there is currently no consensus...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
“...INTRODUCTION: Transitions between different levels of health care, such as hospital admission...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
“... that includes self-evolution as well as noisy initial states and analyse the interrelations between the degree...”
Obter o texto integral
Obter o texto integral
Artigo
5
Por Doessegger, Lucette, Schmitt, Georg, Lenz, Barbara, Fischer, Holger, Schlotterbeck, Götz, Atzpodien, Elke-Astrid, Senn, Hans, Suter, Laura, Csato, Miklos, Evers, Stefan, Singer, Thomas
Publicado em 2013
“... amphiphilic drugs. However, drug-induced PLD is reversible. Evidence of PLD from animal studies with some...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
“... be to use Information Theory as a theoretical foundation for a suitable model of the information flow...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Guerrero-Orriach, Jose Luis, Escalona Belmonte, Juan Jose, Ramirez Fernandez, Alicia, Ramirez Aliaga, Marta, Rubio Navarro, Manuel, Cruz Mañas, Jose
Publicado no Drug Des Devel Ther (2017)
“... is related to the dose-dependent signal, while the degree of protection is related to the concentration...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
“... as toxicology of ambroxol. It has been concluded that even at the highest clinically used doses ambroxol does...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Gahr, Maximilian, Kölle, Markus A, Schönfeldt-Lecuona, Carlos, Lepping, Peter, Freudenmann, Roland W
Publicado em 2011
“... pharmacological profile, including single dosing, predominantly renal excretion, low drug–drug interaction risk...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Sadaie, M. Reza, Farhoudi, Mehdi, Zamanlu, Masumeh, Aghamohammadzadeh, Nasser, Amouzegar, Atieh, Rosenbaum, Robert E., Thomas, Gary A.
Publicado no Ther Adv Drug Saf (2018)
“...). New studies suggest that abnormal serum levels of the nonaromatized potent metabolite of testosterone...”Publicado no Ther Adv Drug Saf (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Celik Kavak, Ebru, Gulcu Bulmus, Funda, Bulmus, Ozgur, Kavak, Salih Burcin, Kocaman, Nevin
Publicado no Drug Des Devel Ther (2018)
“... Index levels in the torsion–detorsion group compared to Group 2 (p<0.001). CONCLUSION: Histopathological...”Publicado no Drug Des Devel Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Reijers, Joannes A. A., Kallend, D. G., Malone, K. E., Jukema, J. W., Wijngaard, P. L. J., Burggraaf, J., Moerland, M.
Publicado no Cardiovasc Drugs Ther (2017)
“... levels were 0.8 (1.9), 0.7 (1.5), 1.0 (2.0) for respectively HV, sCAD, aCAD. The corresponding ETC-216...”Publicado no Cardiovasc Drugs Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Yang, Jun, Bogni, Alessia, Cheng, Cheng, Bleibel, Wasim K., Cai, Xiangjun, Fan, Yiping, Yang, Wenjian, Rocha, Jose Claudio C., Pei, Deqing, Liu, Wei, Dolan, M. Eileen, Pui, Ching-Hon, Relling, Mary V.
Publicado em 2008
“... not develop t-AML, 2) epipodophyllotoxin-related toxicity in t-AML cases and controls, and 3) the level...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Erkılıç, E, Kesimci, E, Alaybeyoğlu, F, Kılınç, I, Tural, R, Yazgan, A, Gümüş, T, Sepici Dinçel, A, Dumlu, EG, Kanbak, O
Publicado no Drug Des Devel Ther (2017)
“...: The plasma NGAL levels exhibited increase at T1, T2, and T3 compared to the levels at T0 in group S (P<0.05...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Porteiro, Begoña, Fondevila, Marcos F., Buque, Xabier, Gonzalez-Rellan, Maria J., Fernandez, Uxia, Mora, Alfonso, Beiroa, Daniel, Senra, Ana, Gallego, Rosalia, Fernø, Johan, López, Miguel, Sabio, Guadalupe, Dieguez, Carlos, Aspichueta, Patricia, Nogueiras, Rubén
Publicado no Mol Metab (2017)
“... in the liver and in two human hepatic cells lines (HepG2 and THLE2). RESULTS: The attenuation of liver damage...”Publicado no Mol Metab (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Begoña Porteiro, Marcos F. Fondevila, Xabier Buque, Maria J. Gonzalez-Rellan, Uxia Fernandez, Alfonso Mora, Daniel Beiroa, Ana Senra, Rosalia Gallego, Johan Fernø, Miguel López, Guadalupe Sabio, Carlos Dieguez, Patricia Aspichueta, Rubén Nogueiras
Publicado em 2018-02-01
“... in the liver and in two human hepatic cells lines (HepG2 and THLE2). Results: The attenuation of liver damage...”Publicado em 2018-02-01
Obter o texto integral
Artigo
17
“... repeated measurements on patients, none of the studies attempted to model patient-level variability...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Bastian, Anja, Thorpe, Jessica E., Disch, Bryan C., Bailey-Downs, Lora C., Gangjee, Aleem, Devambatla, Ravi K. V., Henthorn, Jim, Humphries, Kenneth M., Vadvalkar, Shraddha S., Ihnat, Michael A.
Publicado no J Pharmacol Exp Ther (2015)
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado no J Pharmacol Exp Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Ratcliff, Roger, Smith, Philip L., Brown, Scott D., McKoon, Gail
Publicado no Trends Cogn Sci (2016)
“.... The standard model assumes that evidence accumulates at a constant rate during the second or two it takes...”Publicado no Trends Cogn Sci (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Sewing, Sabine, Gubler, Marcel, Gérard, Régine, Avignon, Blandine, Mueller, Yasmin, Braendli-Baiocco, Annamaria, Odin, Marielle, Moisan, Annie
Publicado no Mol Ther Nucleic Acids (2018)
“...Targeted delivery of antisense oligonucleotide (AON) drugs is a promising strategy to increase...”Publicado no Mol Ther Nucleic Acids (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo